RT @CochraneJapan: カナダよりCOVID19のガイドラインが発表されました。 1. ARDSを伴う患者へステロイドを使用 2. ARDSを伴わない患者へステロイドを使用しない 3. 抗インフルエンザ薬を使用しない 上記について、低〜非常に低いエビデンスでは…
RT @CochraneJapan: カナダよりCOVID19のガイドラインが発表されました。 1. ARDSを伴う患者へステロイドを使用 2. ARDSを伴わない患者へステロイドを使用しない 3. 抗インフルエンザ薬を使用しない 上記について、低〜非常に低いエビデンスでは…
RT @CochraneJapan: カナダよりCOVID19のガイドラインが発表されました。 1. ARDSを伴う患者へステロイドを使用 2. ARDSを伴わない患者へステロイドを使用しない 3. 抗インフルエンザ薬を使用しない 上記について、低〜非常に低いエビデンスでは…
カナダよりCOVID19のガイドラインが発表されました。 1. ARDSを伴う患者へステロイドを使用 2. ARDSを伴わない患者へステロイドを使用しない 3. 抗インフルエンザ薬を使用しない 上記について、低〜非常に低いエビデンスではありますが、弱く推奨されています。 https://t.co/Px7X90rAG5
@heliobeltrao @paulocruzphi Hélio, a Canadian Medical Association Journal também não recomenda a HCQ para tratamento em pacientes em casos não graves. Não tenho informação no estado dos "trials" que eles fizeram, mas segue a edição do "journal": https://t
RT @HEI_mcmaster: Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. Read more here: ht…
RT @HEI_mcmaster: Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. Read more here: ht…
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. Read more here: https://t.co/Lu985a3TLT. #COVID19 https://t.co/YlKiWTpEP8
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @0waki: COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
RT @0waki: COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
@CMAJ Guía basada en la evidencia según metodología GRADE de tratamientos para #coronavirus https://t.co/kZH3rfvqen
RT @0waki: COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
Given the largely very low-quality evidence regarding benefits of the treatments that the panel considered, and given the panel’s inferences regarding patient values and preferences, the panel made almost exclusively weak recommendations →治験中 https://t.c
RT @0waki: COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
RT @0waki: COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
COVID-19治療についてのカナダのガイドライン。 https://t.co/9lSX38Rqgk 血漿療法、抗ウイルス薬(アビガン、カレトラほか)はいずれもエビデンスがないので「行わないよう弱く推奨」。薬のせいで死ぬ可能性にも言及あり。
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/49P9XGaPEP #covid19
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @StephenLap: Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI…
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
RT @CCCForum: Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
RT @CCCForum: Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
Steroids for #COVID19 lung disease? Now two reputable papers in favor: https://t.co/HDHPGf7FSO https://t.co/6iMRAjWiLI Time to consider? Perhaps it’s in the timing - as the inflamm response surges, not too early, not too late! (Image below from https
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
RT @CCCForum: Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
RT @CCCForum: Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
RT @CCCForum: Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
Evidence-based management guidelines for #COVID19 in @CMAJ https://t.co/BZbYT7HJG5
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
RT @KariTikkinen: On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available ev…
On this @CMAJ podcast - my mentor & very good friend - Prof Gordon Guyatt from McMaster University discusses available evidence for many of the treatments being trialed in patients with #COVID19 https://t.co/cnWf9B8rq4 @EBCPMcMaster @HEI_mcmaster @Mc
RT @KariTikkinen: Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii…
Superb guideline on #COVID treatment https://t.co/UfDswXuzMX i) Weak recommendation in FAVOUR: corticosteroids in ARDS ii) Weak recommendations AGAINST: - corticosteroids without ARDS - convalescent plasma - several antiviral drugs iii) Rigorous randomize
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @carpe_diem0820: カナダ内科学会COVID-19治療ガイドライン ARDSの患者にステロイドを使用すること、ない患者に使用しないこと、重症患者に回復期の血漿を使用することに「弱い」推奨 Treatment of patients with nonseve…
RT @carpe_diem0820: カナダ内科学会COVID-19治療ガイドライン ARDSの患者にステロイドを使用すること、ない患者に使用しないこと、重症患者に回復期の血漿を使用することに「弱い」推奨 Treatment of patients with nonseve…
RT @carpe_diem0820: カナダ内科学会COVID-19治療ガイドライン ARDSの患者にステロイドを使用すること、ない患者に使用しないこと、重症患者に回復期の血漿を使用することに「弱い」推奨 Treatment of patients with nonseve…
RT @carpe_diem0820: カナダ内科学会COVID-19治療ガイドライン ARDSの患者にステロイドを使用すること、ない患者に使用しないこと、重症患者に回復期の血漿を使用することに「弱い」推奨 Treatment of patients with nonseve…
カナダ内科学会COVID-19治療ガイドライン ARDSの患者にステロイドを使用すること、ない患者に使用しないこと、重症患者に回復期の血漿を使用することに「弱い」推奨 Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/UeHh8X1k9K https://t.co/UyMOLGov0l
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
#CanadianMedicalAssociationJournal: Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/GkMAcJxlqn via @CMAJ #COVID19 #publichealth
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
#COVID19 Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/dQt0xyv2lm https://t.co/Lk8dfA3dDA
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @YuriHiranuma: カナダ医学会ジャーナルより Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline http…
RT @YuriHiranuma: カナダ医学会ジャーナルより Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline http…
RT @YuriHiranuma: カナダ医学会ジャーナルより Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline http…
カナダ医学会ジャーナルより Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/XBM3MLFv7u
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
#5NU519 The importance of evaluating the quality of evidence- health professionals need to know the limitations of research findings
RT @PriamalFear: Early release, published at https://t.co/oLY5MsJl5w on April 29, 2020. Subject to revision. Treatment of patients with no…
Early release, published at https://t.co/oLY5MsJl5w on April 29, 2020. Subject to revision. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidencebased guideline (PDF) https://t.co/U0FEFiUH6n
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @EBCPMcMaster: Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline https://t.co/mSbvdVmS5Y
Hot off the press, an evidence-based guideline that informs you that evidence supporting the proposed COVID-19 treatments is almost all very low quality and provides weak recommendations against all. #COVID19 https://t.co/v5jJxxdpGJ https://t.co/NKmfzS1uO
RT @CMAJ: New guideline endorsed by @AMMICanada and @CEPhealth reviews evidence for using corticosteroids, convalescent plasma and antivira…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @rincondesisifo: (CMAJ) Guía basada en la evidencia de tto de casos leves y graves de #COVID19 https://t.co/v9dVH6r9lk OJO!! https://t.…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
@almagoch @tomhanks En las nuevas guías publicadas con participación mexicana del Dr Luis Colunga Lozano. No recomiendan el uso de plasma convaleciente en pacientes con Covid 19 severo. https://t.co/vKnrGQ354w https://t.co/XQPoe5dDln
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…
RT @docramiro: Guía basada en la evidencia sobre el tratamiento de pacientes graves y no graves con COVID19. https://t.co/Fnyb7ed2t5 https:…